v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
May 31, 2026
May 31, 2025
May 31, 2024
Cash provided by (used in) operating activities:      
Net loss $ (105,158,000) $ (2,181,356,000) $ (222,404,000)
Adjustments for:      
Income tax expense (recovery), net 17,098,000 (121,017,000) (38,872,000)
Unrealized foreign exchange (gain) loss (9,543,000) (18,218,000) 3,756,000
Amortization 67,601,000 133,490,000 126,913,000
Loss (gain) on sale of capital assets (509,000) 928,000 (4,198,000)
Accretion of convertible debt discount 7,914,000 10,863,000 14,459,000
Asset, Impairment Loss 0 2,096,139,000 0
Other than temporary change in fair value of convertible notes receivable 0 21,661,000 42,681,000
Unrealized loss on digital assets 326,000 0 0
Other non-cash items 1,518,000 (2,203,000) 13,626,000
Stock-based compensation 45,940,000 24,289,000 31,769,000
Loss on long-term investments 4,533,000 5,550,000 4,855,000
Loss (gain) on derivative instruments 3,495,000 (2,161,000) 21,172,000
Change in fair value of contingent consideration (15,000,000) 0 (15,790,000)
Change in non-cash working capital:      
Accounts receivable (66,423,000) (17,801,000) (6,575,000)
Prepaids and other current assets (26,898,000) (8,264,000) 13,069,000
Inventory (13,439,000) (13,561,000) (15,578,000)
Accounts payable and accrued liabilities 19,401,000 (22,938,000) 212,000
Net cash used in operating activities (69,144,000) (94,599,000) (30,905,000)
Cash provided by (used in) investing activities:      
Investment in capital and intangible assets (32,987,000) (32,917,000) (29,249,000)
Proceeds from disposal of capital and intangible assets 3,507,000 6,824,000 8,509,000
Investment in digital assets (1,000,000) 0 0
Sale (purchase) of marketable securities, net 29,408,000 (2,515,000) 209,715,000
Investment in long-term investments (3,595,000) 0 0
Proceeds from long-term investments 2,566,000 0 0
Business acquisitions, net of cash acquired (53,699,000) (18,110,000) (60,626,000)
Net cash provided by (used in) investing activities (55,800,000) (46,718,000) 128,349,000
Cash provided by (used in) financing activities:      
Share capital issued, net of cash issuance costs 157,974,000 161,188,000 8,619,000
Cash paid in lieu of fractional shares (159,000) 0 0
Proceeds from warrants 2,367,000 0 0
Proceeds from long-term debt 0 3,450,000 32,621,000
Repayment of long-term debt (25,353,000) (15,506,000) (22,402,000)
Proceeds from convertible debt 0 0 21,553,000
Repayment of convertible debt 0 (330,000) (107,330,000)
Repayment of lease liabilities (5,429,000) (2,900,000) (2,900,000)
Net increase (decrease) in bank indebtedness 1,594,000 (10,852,000) (5,348,000)
Dividend paid to NCI 0 (1,544,000) 0
Net cash provided by (used in) financing activities 130,994,000 133,506,000 (75,187,000)
Effect of foreign exchange on cash and cash equivalents 1,626,000 1,137,000 (549,000)
Net decrease in cash and cash equivalents 7,676,000 (6,674,000) 21,708,000
Cash and cash equivalents, beginning of year 221,666,000 228,340,000 206,632,000
Cash and cash equivalents, end of year $ 229,342,000 $ 221,666,000 $ 228,340,000